Salama Abeer, Mansour Dina, Hegazy Rehab
Pharmacology Department, Medical Division, National Research Centre, 33 El Bohouth St. (Former El-Tahrir St.), 12622 Dokki, Cairo, Egypt.
Toxicol Rep. 2021 Apr 20;8:908-919. doi: 10.1016/j.toxrep.2021.04.008. eCollection 2021.
The expression of angiotensin II type 1 receptor (AT1 receptor)/protein kinase C (PKC) in heart tissues has a vital role in myocardial infarction (MI). The current work aimed to clarify the renal complication enhanced by MI following epinephrine injection via AT1 receptor/ PKC expression; in addition, the impact of ginseng extract on epinephrine-induced MI and its renal complication was assessed. Adult male albino Wistar rats were pretreated orally with ginseng extract (200 & 400 mg/kg/day) for 14 days, then two successive doses of epinephrine injection (100 mg/kg, i.p.). Epinephrine evoked electrocardiographic (ECG) and renal changes accompanied with a significant increase in heart and kidney contents of malodialdehyde (MDA), nitric oxide (NO), protein kinase C (PKC), heart contents of nuclear factor-kabba B (NF-κB) and angiotensin 1receptor (AT1R), as well as a decrease in heart and kidney reduced glutathione (GSH) and nuclear factor-erythroid-related factor 2 (Nrf2) contents. In histopathological investigations epinephrine exhibited deleterious heart changes in the form of acute MI with the presence of necrosis of cardiomyocytes with iNOS expression and produced glomerulus and renal tubules degeneration. Pretreatment of rats with ginseng extract in both doses significantly corrected epinephrine-induced heart and renal changes. The current work revealed that epinephrine-induced MI associated with aggravated renal complication and ginseng extract has cardio and reno protective role against this as it reduces infarct size, preserves cardiac and renal tissues and functions through activating Nrf2 and down-regulating NF-κB, PKC, AT1R and iNOS.
心脏组织中血管紧张素II 1型受体(AT1受体)/蛋白激酶C(PKC)的表达在心肌梗死(MI)中起着至关重要的作用。当前研究旨在通过AT1受体/PKC表达阐明肾上腺素注射后心肌梗死所致的肾脏并发症;此外,评估人参提取物对肾上腺素诱导的心肌梗死及其肾脏并发症的影响。成年雄性白化Wistar大鼠口服人参提取物(200和400毫克/千克/天)预处理14天,然后连续两次腹腔注射肾上腺素(100毫克/千克)。肾上腺素引起心电图(ECG)和肾脏变化,同时心脏和肾脏中的丙二醛(MDA)、一氧化氮(NO)、蛋白激酶C(PKC)含量显著增加,心脏中的核因子-κB(NF-κB)和血管紧张素1受体(AT1R)含量增加,以及心脏和肾脏中还原型谷胱甘肽(GSH)和核因子-红细胞相关因子2(Nrf2)含量减少。在组织病理学检查中,肾上腺素表现出有害的心脏变化,表现为急性心肌梗死,伴有心肌细胞坏死和诱导型一氧化氮合酶(iNOS)表达,并导致肾小球和肾小管变性。两种剂量的人参提取物预处理大鼠均显著纠正了肾上腺素引起的心脏和肾脏变化。当前研究表明,肾上腺素诱导的心肌梗死与加重的肾脏并发症相关,人参提取物对此具有心脏和肾脏保护作用,因为它通过激活Nrf2和下调NF-κB、PKC、AT1R和iNOS来减小梗死面积,保护心脏和肾脏组织及功能。